Melanie Marshall
Directeur Technique/Scientifique/R&D chez OSSDSIGN AB
Postes actifs de Melanie Marshall
Sociétés | Poste | Début | Fin |
---|---|---|---|
OSSDSIGN AB | Directeur Technique/Scientifique/R&D | 01/01/2022 | - |
Historique de carrière de Melanie Marshall
Anciens postes connus de Melanie Marshall
Sociétés | Poste | Début | Fin |
---|---|---|---|
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Directeur Technique/Scientifique/R&D | 20/11/2009 | - |
Formation de Melanie Marshall
Wheaton College (Massachusetts) | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 2 |
Suède | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
OSSDSIGN AB | Health Technology |
Entreprise privées | 1 |
---|---|
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Health Technology |
- Bourse
- Insiders
- Melanie Marshall
- Expérience